Biogen Idec/Elan Tysabri Guaranteed Coverage Under Medicare Part B

Biogen Idec/Elan's once-monthly I.V. formulation of the multiple sclerosis therapy Tysabri guarantees that the product will be covered under Medicare Part B

More from Archive

More from Pink Sheet